Objective:Crizotinib has demonstrated promising efficacy in patients with anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) in clinic
Objective:Our goal is to analyze the trend of colorectal cancer (CRC) regarding the death,incidence and prevalence rates over time,and to provide epidemiologica
Objective:Currendy,no satisfactory targets for colorectal cancer or markers for immunotherapy and diagnosis and prognosis are available.Immunoglobulin G (IgG) i